CEBL.DE vs. FBT.L
CEBL.DE (iShares MSCI EM Asia UCITS ETF (Acc)) and FBT.L (First Trust NYSE Arca Biotechnology UCITS ETF Acc) are both exchange-traded funds - CEBL.DE is a Asia Pacific Equities fund tracking the MSCI Emerging Markets Asia, while FBT.L is a Health & Biotech Equities fund tracking the NASDAQ Biotechnology TR USD. Both are passively managed. Over the past 5 years, CEBL.DE returned 8.97%/yr vs 7.95%/yr for FBT.L. At a 0.28 correlation, their price movements are largely independent. CEBL.DE charges 0.20%/yr vs 0.60%/yr for FBT.L.
Performance
CEBL.DE vs. FBT.L - Performance Comparison
Loading charts...
Different Trading Currencies
CEBL.DE is traded in EUR, while FBT.L is traded in GBp. To make them comparable, the FBT.L values have been converted to EUR using the latest available exchange rates.
Returns By Period
In the year-to-date period, CEBL.DE achieves a 31.90% return, which is significantly higher than FBT.L's 9.96% return.
CEBL.DE
- 1D
- -1.89%
- 1M
- 5.19%
- YTD
- 31.90%
- 6M
- 32.33%
- 1Y
- 54.45%
- 3Y*
- 22.99%
- 5Y*
- 8.97%
- 10Y*
- 11.02%
FBT.L
- 1D
- 4.29%
- 1M
- 8.25%
- YTD
- 9.96%
- 6M
- 7.37%
- 1Y
- 37.14%
- 3Y*
- 10.19%
- 5Y*
- 7.95%
- 10Y*
- —
CEBL.DE vs. FBT.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
CEBL.DE iShares MSCI EM Asia UCITS ETF (Acc) | 31.90% | 19.13% | 18.60% | 3.15% | -15.54% | 2.03% | 26.23% |
FBT.L First Trust NYSE Arca Biotechnology UCITS ETF Acc | 9.96% | 11.35% | 12.25% | 0.68% | -1.22% | 3.77% | -2.13% |
Correlation
The correlation between CEBL.DE and FBT.L is 0.31, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.31 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.25 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.29 |
Correlation (All Time) Calculated using the full available price history since Jun 16, 2020 | 0.28 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CEBL.DE vs. FBT.L — Risk / Return Rank
CEBL.DE
FBT.L
CEBL.DE vs. FBT.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares MSCI EM Asia UCITS ETF (Acc) (CEBL.DE) and First Trust NYSE Arca Biotechnology UCITS ETF Acc (FBT.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| CEBL.DE | FBT.L | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.09 | ||
| Sortino ratioReturn per unit of downside risk | +1.17 | ||
| Omega ratioGain probability vs. loss probability | 1.50 | 1.30 | +0.19 |
| Calmar ratioReturn relative to maximum drawdown | 4.83 | 2.70 | +2.14 |
| Martin ratioReturn relative to average drawdown | 17.67 | 6.95 | +10.72 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| CEBL.DE | FBT.L | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.81 | 1.72 | +1.09 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.48 | 0.49 | -0.01 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.58 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.43 | 0.34 | +0.09 |
Drawdowns
CEBL.DE vs. FBT.L - Drawdown Comparison
The maximum CEBL.DE drawdown since its inception was -35.09%, which is greater than FBT.L's maximum drawdown of -26.40%. Use the drawdown chart below to compare losses from any high point for CEBL.DE and FBT.L.
Loading charts...
Drawdown Indicators
| CEBL.DE | FBT.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -35.09% | -26.40% | -8.69% |
Max Drawdown (1Y)Largest decline over 1 year | -11.43% | -13.29% | +1.86% |
Max Drawdown (3Y)Largest decline over 3 years | -20.53% | -26.11% | +5.58% |
Max Drawdown (5Y)Largest decline over 5 years | -29.00% | -26.11% | -2.89% |
Max Drawdown (10Y)Largest decline over 10 years | -33.12% | — | — |
Current DrawdownCurrent decline from peak | -2.85% | 0.00% | -2.85% |
Average DrawdownAverage peak-to-trough decline | -11.09% | -11.01% | -0.08% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.13% | 5.17% | -2.04% |
Volatility
CEBL.DE vs. FBT.L - Volatility Comparison
iShares MSCI EM Asia UCITS ETF (Acc) (CEBL.DE) has a higher volatility of 8.24% compared to First Trust NYSE Arca Biotechnology UCITS ETF Acc (FBT.L) at 6.80%. This indicates that CEBL.DE's price experiences larger fluctuations and is considered to be riskier than FBT.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CEBL.DE | FBT.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.24% | 6.80% | +1.44% |
Volatility (6M)Calculated over the trailing 6-month period | 16.36% | 15.39% | +0.97% |
Volatility (1Y)Calculated over the trailing 1-year period | 19.68% | 20.79% | -1.11% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 18.48% | 23.14% | -4.66% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.94% | 24.32% | -5.38% |
CEBL.DE vs. FBT.L - Expense Ratio Comparison
CEBL.DE has a 0.20% expense ratio, which is lower than FBT.L's 0.60% expense ratio.
Dividends
CEBL.DE vs. FBT.L - Dividend Comparison
Neither CEBL.DE nor FBT.L has paid dividends to shareholders.
Frequently Asked Questions
CEBL.DE and FBT.L have a correlation of 0.31, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, CEBL.DE is cheaper at 0.20% per year. The better choice depends on whether you care most about return, fees, risk, or income.
CEBL.DE is cheaper with a 0.20% expense ratio, compared with 0.60% for FBT.L.
CEBL.DE is categorized as Asia Pacific Equities, while FBT.L is Health & Biotech Equities. CEBL.DE tracks MSCI Emerging Markets Asia, while FBT.L tracks NASDAQ Biotechnology TR USD. They also come from different issuers: iShares and First Trust. Their fees differ too: 0.20% for CEBL.DE and 0.60% for FBT.L.
Find the right allocation for CEBL.DE and FBT.L
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer